Question explored with the scientific record
Conversation so far
- 1 growing the knee
- 2 new treatment for an arthritic knee
Answered on this page ↓
new treatment for an arthritic knee
The short version: nothing new actually repairs the joint. The best-supported options are exercise, PRP injections, and hyaluronic acid, all of which buy pain relief measured in months, not years.
A 2024 review of nonsurgical treatments is blunt: there is no disease-modifying drug for osteoarthritis, exercise and bracing have the strongest evidence, and most of the flashy options (hyaluronic acid, stem cells, prolotherapy) have limited or insufficient support [1]. That review declared no funding conflicts [1].
The newer injectables look better than placebo in small trials, but the trials are small. Platelet-rich plasma beat saline for pain and function over 6 months in a 20-person trial, with no strength advantage and no serious adverse events [2]. A larger 111-person trial found PRP beat hyaluronic acid on pain and function at 6 months [9]. Hyaluronic acid itself helps for about 6 months, then returns to baseline by 1 year, with one case of septic arthritis in 48 patients [7]. Combining hyaluronic acid with a steroid gave greater and longer relief than hyaluronic acid alone in a 40-per-group study [8], and worked better in moderate than severe disease [6].
| Treatment | Evidence | Duration shown |
|---|---|---|
| PRP | RCT, n=20 [2]; beat HA, n=111 [9] | 6 months |
| HA + steroid | Observational, n=40 [8] | 6 months, peak [6] |
| HA alone | Single-arm, n=48 [7] | 6 months, gone at 1 year |
| Curcumin extract | RCT, n=70 [3] | 12 weeks, modest pain relief |
| MSC secretome | Matched cohort, small, 3 months [5] | Too early |
The genuinely new stuff is preclinical. Urolithin A protected cartilage and reduced pain in mice [4]; stem-cell subpopulations regenerated cartilage in rats [10]; MSC secretome showed 3-month benefit in a small matched cohort [5]. None of this has been proven in humans.
What this retrieval did not surface: any large, long-term randomized trial of PRP or stem-cell products against true placebo beyond 12 months, and no head-to-head cost data. The injection market is also lightly regulated compared to drugs, so expect the published record to overstate benefit.
My call: for a painful arthritic knee, exercise first, then PRP or HA plus steroid if you want months of relief, with the honest expectation that nothing here changes the disease. Confidence: moderate for PRP and HA symptom relief, low for everything marketed as regenerative.
Sources used 10
-
Evidence-Based Review of Nonsurgical Treatments for Knee and Hip Osteoarthritis
An evidence-based narrative review summarizing nonsurgical treatments for knee and hip osteoarthritis, highlighting evidence supporting exercise and bracing, NSAIDs/acetaminophen/intra-articular corticosteroids for pain relief, and noting limited support for other modalities, wi…
DOI: 10.5152/eurjrheum.2024.22096 -
Effects of Platelet-Rich Plasma on Pain and Muscle Strength in Patients With Knee Osteoarthritis
In a randomized, double-blind, placebo-controlled trial in 20 adults with bilateral knee osteoarthritis, intra-articular platelet-rich plasma (PRP) improved pain and function more than saline over 6 months, while muscle strength showed limited and inconsistent superiority for PR…
DOI: 10.1097/PHM.0000000000000874 -
Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion–Synovitis of Knee Osteoarthritis
A 12-week, randomized, double-blind, placebo-controlled trial in southern Tasmania found that Curcuma longa extract modestly reduces knee pain in knee osteoarthritis with effusion-synovitis but does not affect effusion-synovitis volume or cartilage T2 relaxation time, with simil…
DOI: 10.7326/M20-0990 -
Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis
Urolithin A (Mitopure) enhances mitophagy and mitochondrial respiration in human chondrocytes from healthy and OA joints, reduces cartilage degeneration and inflammation, and alleviates pain in a mouse model of osteoarthritis, supporting UA as a mitochondria-targeted therapeutic…
DOI: 10.1111/acel.13662 -
The Differences in Cartilaginous Oligomeric Matrix Protein Levels and Womac Scores in Knee OA Patients 3 Months After Mesenchymal Stem Cell Secretome Injection Compared with Hyaluronic Acid Injection
In a matched-pair cohort of knee osteoarthritis patients, intra-articular MSC secretome injection was associated with significant pain and functional improvement at three months and favorable outcome values compared with hyaluronic acid, though limited by small samples and short…
DOI: 10.52403/ijrr.20260652 -
Efficacy Of Hyaluronic Acid And Corticosteroid Intra-Articular Injection In Knee Joint With Primary Osteoarthritis
Intra-articular hyaluronic acid plus methylprednisolone improved pain, stiffness, and physical function in knee osteoarthritis patients, with peak improvement at six months and better responses in moderate than severe OA, and appeared safe.
DOI: 10.47723/kcmj.v14i1.24 -
Efficacy, Tolerability and Adverse Events of Single-Shot Intra-Articular Hyaluronic Acid Injection in Knee Osteoarthritis
Single-shot intra-articular hyaluronic acid improved knee osteoarthritis pain and function for up to 6 months, but benefits returned to baseline at 1 year and one septic arthritis occurred.
DOI: 10.33883/jms.v18i2.261 -
Efficacy of combination therapy of Hyaluronic acid and Methylprednisolon verses Hyaluronic acid single therapy in knee Osteoarthritis : A comparative study
In knee osteoarthritis, single-dose intra-articular hyaluronic acid plus methylprednisolone provided greater and longer-lasting relief of pain and knee function than hyaluronic acid alone.
DOI: 10.3329/nimcj.v10i2.45429 -
Hyaluronic Acid versus Platelet-Rich Plasma
This double-blind randomized controlled trial compares the clinical outcomes and intra-articular biology of hyaluronic acid versus platelet-rich plasma in treating knee osteoarthritis, finding significant improvements in pain and function with PRP at 6 months post-treatment.
DOI: 10.1177/2325967115S00123 -
Identification of a sub-population of synovial mesenchymal stem cells with enhanced treatment efficacy in a rat model of osteoarthritis
Identifying a CD47-high subpopulation of clonally derived human synovial MSCs reveals superior cartilage regeneration in a rat OA model, highlighting MSC heterogeneity and offering a marker to enhance joint repair therapies.
DOI: 10.7554/eLife.103332